Derma Sciences Company Profile (NASDAQ:DSCI)

About Derma Sciences

Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Health Care Supplies
• Exchange: NASDAQ
• Symbol: DSCI
• CUSIP: 24982750

Key Metrics:

• Previous Close: $4.93
• 50 Day Moving Average: $4.89
• 200 Day Moving Average: $4.05
• 52-Week Range: $28,305,000.00 - $2.85
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: 49.30
• P/E Growth: 0.00
• Market Cap: $139.54M
• Outstanding Shares: 28,305,000
• Beta: 0.88

Profitability:

• Net Margins: -21.19%
• Return on Equity: -11.74%
• Return on Assets: -10.31%

Debt:

• Current Ratio: 8.34%
• Quick Ratio: 6.24%

Additional Links:

• Visit Derma Sciences' Official Website
• View DSCI on Google Finance
• View DSCI on Yahoo Finance
• View DSCI's Company Profile on Reuters
• Search for Derma Sciences Inc. on Google

Companies Related to Derma Sciences:

• Invitae Corp. (NYSE:NVTA)
• Concordia Healthcare Corp. (NASDAQ:CXRX)
• Oxford Immunotec Global PLC (NASDAQ:OXFD)
• Ignyta (NASDAQ:RXDX)
• AxoGen (NASDAQ:AXGN)
• Chimerix (NASDAQ:CMRX)
• Zogenix (NASDAQ:ZGNX)
• Lantheus Holdings (NASDAQ:LNTH)
• Nutraceutical International Corp. (NASDAQ:NUTR)
• Tandem Diabetes Care (NASDAQ:TNDM)

Earnings

Earnings History for Derma Sciences (NASDAQ:DSCI)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/7/2016
8/9/2016	Q216	($0.08)	$0.08	$22.40 million	$22.20 million	View	Listen
5/11/2016	Q116	($0.13)	($0.07)	$20.60 million	$20.20 million	View	Listen
3/16/2016	Q415	($0.39)	($0.38)	$20.21 million	$20.30 million	View	Listen
11/9/2015	Q315	($0.43)	($0.35)	$22.31 million	$22.20 million	View	Listen
8/10/2015	Q215	($0.43)	($0.36)	$21.66 million	$22.60 million	View	Listen
5/11/2015	Q115	($0.46)	($0.42)	$19.89 million	$19.50 million	View	Listen
3/12/2015	Q414	($0.45)	($0.37)	$22.90 million	$22.90 million	View	Listen
11/10/2014	Q314	($0.43)	($0.45)	$21.90 million	$20.20 million	View	N/A
8/7/2014	Q2	($0.46)	($0.34)			View	Listen
5/8/2014	Q1	($0.32)	($0.46)	$19.79 million	$19.80 million	View	Listen
3/14/2014	Q4	($0.36)	($0.31)	$21.26 million	$20.70 million	View	Listen
11/13/2013	Q3	($0.44)	($0.29)	$21.96 million	$22.10 million	View	Listen
8/12/2013	Q2 2013	($0.45)	($0.43)	$19.95 million	$18.10 million	View	Listen
5/16/2013	Q1 2013	($0.37)	($0.38)	$19.00 million	$18.80 million	View	Listen
11/12/2012	Q312	($0.37)	($0.24)	$19.00 million	$19.60 million	View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Derma Sciences (NASDAQ:DSCI)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.13)	($0.13)	($0.13)
Q2 2016	1	($0.08)	($0.08)	($0.08)
Q3 2016	1	($0.04)	($0.04)	($0.04)
Q4 2016	1	$0.00	$0.00	$0.00

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Derma Sciences (NASDAQ:DSCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Derma Sciences (NASDAQ:DSCI)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
8/18/2015	Srini Conjeevaram	Director	Buy	1,100	$6.50	$7,150.00
8/14/2015	Samuel E Navarro	Director	Buy	10,000	$6.51	$65,100.00
8/13/2015	Bruce F Wesson	Director	Buy	10,000	$6.58	$65,800.00
8/13/2015	Edward J Quilty	CEO	Buy	15,000	$6.65	$99,750.00
8/13/2015	Robert C Cole	Insider	Buy	5,000	$6.73	$33,650.00
6/12/2015	Brett Hewlett	Director	Sell	12,000	$7.17	$86,040.00
12/15/2014	Srini Conjeevaram	Director	Sell	12,500	$8.49	$106,125.00
12/4/2014	C Richard Stafford	Director	Sell	6,075	$8.59	$52,184.25
11/25/2014	C Richard Stafford	Director	Sell	1,775	$8.26	$14,661.50
11/18/2014	C Richard Stafford	Director	Sell	3,250	$8.59	$27,917.50
11/17/2014	C Richard Stafford	Director	Sell	1,800	$8.50	$15,300.00
11/14/2014	C Richard Stafford	Director	Sell	5,073	$8.48	$43,019.04
9/16/2014	Barry Wolfenson	Insider	Buy	3,750	$7.99	$29,962.50
5/19/2014	Barry Wolfenson	Insider	Buy	11,250	$8.79	$98,887.50
5/16/2014	Edward Quilty	CEO	Buy	10,000	$8.70	$87,000.00
1/10/2014	Ra Capital Management, Llc	Insider	Sell	300,000	$11.83	$3,549,000.00
9/3/2013	C Richard Stafford	Director	Sell	15,000	$14.06	$210,900.00
9/3/2013	John Yetter	CFO	Sell	12,100	$14.16	$171,336.00
5/30/2013	William C Martin	Major Shareholder	Sell	95,568	$13.68	$1,307,370.24
4/29/2013	Ra Capital Management, Llc	Major Shareholder	Buy	3,945	$11.40	$44,973.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Derma Sciences (NASDAQ:DSCI)

Date	Headline
	LabCorp: Strong Fundamentals, Sequenom Buyout Raise Hope (NASDAQ:DSCI) finance.yahoo.com - September 23 at 9:43 AM
	Medtronic (MDT): Valiant Captivia Data Positive at Three Years (NASDAQ:DSCI) finance.yahoo.com - September 23 at 9:43 AM
	Derma Sciences, Inc. (NASDAQ:DSCI) EPS Estimate At $0 - Investor Newswire (NASDAQ:DSCI) www.investornewswire.com - September 22 at 4:47 PM
	Derma Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:DSCI) finance.yahoo.com - September 21 at 5:12 PM
	Align Technology: Invisalign Growth Continues Globally (NASDAQ:DSCI) www.zacks.com - September 21 at 8:59 AM
	DERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and (NASDAQ:DSCI) biz.yahoo.com - September 9 at 9:30 AM
	Shares Trading Lower in Today's Session: Derma Sciences Inc. (NASDAQ:DSCI) - Post News (NASDAQ:DSCI) www.kentuckypostnews.com - September 7 at 5:24 AM
	Others Overlooked Derma Sciences (DSCI), Should You Buy It Now? (NASDAQ:DSCI) finance.yahoo.com - August 30 at 12:16 PM
	DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:DSCI) biz.yahoo.com - August 27 at 8:53 AM
	Derma Sciences (DSCI) Launches New MEDIHONEY Hydrogel Sheet Dressings; HCPCS Codes Received (NASDAQ:DSCI) www.streetinsider.com - August 26 at 4:01 PM
	Derma Sciences (DSCI) Says AMNIOEXCEL Will be Considered for Coverage by NGS - StreetInsider.com (NASDAQ:DSCI) www.streetinsider.com - August 26 at 7:48 AM
	LabCorp's Takeover of Sequenom Wins Antitrust Clearance (NASDAQ:DSCI) www.zacks.com - August 25 at 4:45 PM
	Derma Sciences Receives Reimbursement Coding for New MEDIHONEY ® Hydrogel Dressings (NASDAQ:DSCI) www.businesswire.com - August 25 at 4:45 PM
	Derma Sciences Receives Reimbursement Coding for New MEDIHONEY Hydrogel Dressings (NASDAQ:DSCI) www.cbs58.com - August 25 at 9:39 AM
	Derma Sciences Receives Reimbursement Coding for New MEDIHONEY® Hydrogel Dressings (NASDAQ:DSCI) www.publicnow.com - August 25 at 9:39 AM
	BRIEF-Derma Sciences gets reimbursement coding for medihoney hydrogel dressings (NASDAQ:DSCI) feeds.reuters.com - August 25 at 8:24 AM
	Derma Sciences' AMNIOEXCEL® Now Eligible For Reimbursement By Medicare Administrative Contractor NGS (NASDAQ:DSCI) www.thestreet.com - August 24 at 4:39 PM
	Derma Sciences’ AMNIOEXCEL® Now Eligible for Reimbursement by Medicare Administrative Contractor NGS (NASDAQ:DSCI) www.publicnow.com - August 24 at 4:39 PM
	Edited Transcript of DSCI earnings conference call or presentation 9-Aug-16 3:00pm GMT (NASDAQ:DSCI) finance.yahoo.com - August 18 at 4:44 PM
	Derma Sciences Names Russell Olsen President of Advanced Wound Care (NASDAQ:DSCI) www.publicnow.com - August 18 at 8:04 AM
	DERMA SCIENCES, INC. Financials (NASDAQ:DSCI) finance.yahoo.com - August 17 at 4:51 PM
	ETF’s with exposure to Derma Sciences, Inc. : August 17, 2016 (NASDAQ:DSCI) www.capitalcube.com - August 17 at 4:51 PM
	Derma Sciences, Inc. :DSCI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:DSCI) www.capitalcube.com - August 15 at 4:51 PM
	DERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equ (NASDAQ:DSCI) biz.yahoo.com - August 11 at 10:32 PM
	Derma Sciences Inc.: Derma Sciences Reports 2016 Second Quarter Financial Results (NASDAQ:DSCI) www.twst.com - August 9 at 3:21 PM
	Derma Sciences posts 2Q profit (NASDAQ:DSCI) sg.finance.yahoo.com - August 9 at 3:21 PM
	Q2 2016 Derma Sciences Inc Earnings Release - Before Market Open (NASDAQ:DSCI) biz.yahoo.com - August 9 at 7:58 AM
	Derma Sciences Reports 2016 Second Quarter Financial Results (NASDAQ:DSCI) finance.yahoo.com - August 9 at 7:58 AM
	DERMA SCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) (NASDAQ:DSCI) www.4-traders.com - August 8 at 10:03 PM
	DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:DSCI) biz.yahoo.com - August 8 at 10:03 PM
	Derma Sciences Inc. (DSCI) Jumps 5.44% on August 03 - Equities.com (NASDAQ:DSCI) www.equities.com - August 5 at 9:58 PM
	Derma Sciences Inc. (DSCI) Jumps 5.44% on August 03 (NASDAQ:DSCI) www.equities.com - August 4 at 10:27 PM
	Derma Sciences Inc.: Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th (NASDAQ:DSCI) www.twst.com - August 4 at 4:56 PM
	Derma Sciences Inc.: Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th (NASDAQ:DSCI) www.twst.com - August 4 at 4:56 PM
	Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th (NASDAQ:DSCI) www.publicnow.com - August 3 at 4:50 PM
	DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal (NASDAQ:DSCI) biz.yahoo.com - August 1 at 6:06 AM
	Derma Sciences Inc. (DSCI) Jumps 12.53% on July 28 - Equities.com (NASDAQ:DSCI) www.equities.com - July 29 at 10:02 PM
	$77.8M deal: Princeton tissue regeneraton firm buys Tennessee company (NASDAQ:DSCI) www.bizjournals.com - July 28 at 9:07 PM
	Derma Sciences Inc. (DSCI) Jumps 12.53% on July 28 (NASDAQ:DSCI) www.equities.com - July 28 at 9:07 PM
	Derma Sciences Inc. (DSCI) Jumps 6.16% on July 27 - Equities.com (NASDAQ:DSCI) www.equities.com - July 28 at 3:23 PM
	Derma Sciences (DSCI) to Acquire BioD in ~$77.8M Deal - StreetInsider.com (NASDAQ:DSCI) www.streetinsider.com - July 28 at 3:23 PM
	Derma Sciences (DSCI) to Acquire BioD in ~$77.8M Deal (NASDAQ:DSCI) www.streetinsider.com - July 28 at 9:29 AM
	BRIEF-Derma Sciences to acquire BIOD (NASDAQ:DSCI) feeds.reuters.com - July 28 at 8:28 AM
	Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products (NASDAQ:DSCI) www.publicnow.com - July 28 at 7:48 AM
	7:31 am Derma Sciences to acquire BioD for an immediate transaction value of $21.3 mln, expects immediate accretion; announces a 42.0 mln private placement at $4.17/share, plans to guide for FY16 in August (NASDAQ:DSCI) finance.yahoo.com - July 28 at 7:31 AM
	Derma Sciences Inc. (DSCI) Jumps 6.16% on July 27 (NASDAQ:DSCI) www.equities.com - July 27 at 10:21 PM
	Derma Sciences (DSCI) Enters Agreement to Sell FAD Division in $12.2M Deal (NASDAQ:DSCI) www.streetinsider.com - July 27 at 10:21 PM
	Derma Sciences (DSCI) Enters Agreement to Sell FAD Division in $12.2M Deal - StreetInsider.com (NASDAQ:DSCI) www.streetinsider.com - July 27 at 4:47 PM
	BRIEF-Derma Sciences to sell First-Aid Products division for $12.2 million (NASDAQ:DSCI) feeds.reuters.com - July 27 at 9:09 AM
	Derma Sciences to Sell First Aid Products Division for Approximately $12.2 Million (NASDAQ:DSCI) www.publicnow.com - July 27 at 7:38 AM

Social

Derma Sciences (NASDAQ:DSCI) Chart for Monday, September, 26, 2016